MENU
+Compare
DAWN
Stock ticker: NASDAQ
AS OF
Apr 3, 04:59 PM (EDT)
Price
$7.72
Change
-$0.25 (-3.14%)
Capitalization
807.8M

DAWN Day One Biopharmaceuticals Forecast, Technical & Fundamental Analysis

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more

DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for DAWN with price predictions
Apr 02, 2025

DAWN's RSI Oscillator recovers from oversold territory

The RSI Oscillator for DAWN moved out of oversold territory on April 02, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 24 similar instances when the indicator left oversold territory. In of the 24 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for DAWN just turned positive on March 20, 2025. Looking at past instances where DAWN's MACD turned positive, the stock continued to rise in of 35 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DAWN advanced for three days, in of 234 cases, the price rose further within the following month. The odds of a continued upward trend are .

DAWN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on DAWN as a result. In of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DAWN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for DAWN entered a downward trend on April 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.607) is normal, around the industry mean (13.260). P/E Ratio (0.000) is within average values for comparable stocks, (64.931). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.878). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (5.666) is also within normal values, averaging (252.036).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. DAWN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DAWN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

DAWN is expected to report earnings to fall 35.22% to -40 cents per share on May 07

Day One Biopharmaceuticals DAWN Stock Earnings Reports
Q1'25
Est.
$-0.41
Q4'24
Missed
by $0.17
Q3'24
Beat
by $0.70
Q2'24
Beat
by $0.70
Q1'24
Missed
by $0.07
The last earnings report on February 25 showed earnings per share of -62 cents, missing the estimate of -46 cents. With 396.23K shares outstanding, the current market capitalization sits at 807.80M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2000 Sierra Point Parkway
Phone
+1 650 484-0899
Employees
155
Web
https://www.dayonebio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JDPNX15.250.16
+1.06%
Janus Henderson Mid Cap Value N
BGASX15.680.13
+0.84%
Baillie Gifford Global Alpha Equities I
AINTX15.800.02
+0.13%
Ariel International Investor
SLCCX36.22N/A
N/A
ClearBridge Large Cap Growth C
MRCEX11.97N/A
N/A
Meridian Hedged Equity C

DAWN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, DAWN has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if DAWN jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DAWN
1D Price
Change %
DAWN100%
+4.73%
VCYT - DAWN
43%
Loosely correlated
+1.93%
RVMD - DAWN
40%
Loosely correlated
+2.91%
SYRE - DAWN
40%
Loosely correlated
+1.27%
KROS - DAWN
40%
Loosely correlated
+5.13%
DNLI - DAWN
39%
Loosely correlated
+11.80%
More